IMPROVED MONOCLONAL-ANTIBODY TUMOR BACKGROUND RATIOS WITH EXCHANGE TRANSFUSIONS

被引:7
作者
HENRY, CA
CLAVO, AC
WAHL, RL
机构
[1] UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,DIV NUCL MED,1500 E MED CTR DR,ANN ARBOR,MI 48109
[2] UNIV MICHIGAN,MED CTR,DEPT RADIOL,DIV NUCL MED,ANN ARBOR,MI 48109
来源
NUCLEAR MEDICINE AND BIOLOGY | 1991年 / 18卷 / 05期
关键词
D O I
10.1016/0883-2897(91)90120-A
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Blood exchange transfusions were performed in nude rats with subcutaneous HTB77 human ovarian carcinoma xenografts in an attempt to improve specific monoclonal antibody (MoAb) tumor/non-tumor uptake ratios. Animals were injected intravenously with both I-131-5G6.4 specific and I-125-UPC-10 non-specific MoAb. Twenty-four hours later 65-80% of the original blood was exchanged with normal heparinized rat blood and then these rodents were sacrificed. Exchange transfusion significantly (P < 0.05) decreased normal tissue activities of I-131 (except for muscle) by 63-85%, while tumor activity decreased only 5%. Tumor to background ratios increased from 0.1-0.8 to 2.3-6.3. Exchange transfusions substantially enhance tumor/normal tissue antibody uptake ratios and, along with plasmapheresis, may be useful in enhancing antibody localization in vivo, particularly for therapy.
引用
收藏
页码:565 / 567
页数:3
相关论文
共 16 条
[1]   LIPOSOMALLY ENTRAPPED SECOND ANTIBODY IMPROVES TUMOR IMAGING WITH RADIOLABELED (1ST) ANTI-TUMOR ANTIBODY [J].
BEGENT, RHJ ;
GREEN, AJ ;
BAGSHAWE, KD ;
JONES, BE ;
KEEP, PA ;
SEARLE, F ;
JEWKES, RF ;
BARRATT, GM ;
RYMAN, BE .
LANCET, 1982, 2 (8301) :739-742
[2]  
CHARLTON B, 1983, T AM SOC ART INT ORG, V29, P724
[3]   MEMBRANE PLASMAPHERESIS TECHNIQUE IN RATS - CONFIRMATION OF ANTIBODY REBOUND [J].
EULER, HH ;
KREY, U ;
SCHRODER, O ;
LOFFLER, H .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 84 (1-2) :313-319
[4]  
GOLDENBERG DM, 1987, J NUCL MED, V28, P1604
[5]  
GOODWIN DA, 1987, J NUCL MED, V28, P1358
[6]  
PENTEL PR, 1988, DRUG METAB DISPOS, V16, P141
[7]   INTRAPERITONEAL DELIVERY OF MONOCLONAL-ANTIBODIES - ENHANCED REGIONAL DELIVERY ADVANTAGE USING INTRAVENOUS UNLABELED ANTI-MOUSE ANTIBODY [J].
WAHL, RL ;
FISHER, S .
NUCLEAR MEDICINE AND BIOLOGY, 1987, 14 (06) :611-615
[8]  
WAHL RL, 1986, P AM ASSOC CANC RES, V27, P355
[9]  
WAHL RL, 1989, J NUCL MED, V30, P60
[10]  
WAHL RL, 1990, J NUCL MED, V31, P84